Versor Investments’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,585
Closed -$841K 863
2025
Q2
$841K Buy
36,585
+27,085
+285% +$627K 0.15% 211
2025
Q1
$213K Sell
9,500
-27,400
-74% -$637K 0.03% 645
2024
Q4
$721K Buy
+36,900
New +$731K 0.12% 247
2024
Q3
Sell
-10,500
Closed -$182K 943
2024
Q2
$182K Buy
+10,500
New +$186K 0.03% 667
2022
Q3
Sell
-16,400
Closed -$478K 918
2022
Q2
$478K Buy
+16,400
New +$417K 0.02% 492

Other funds holding PRVA

Versor Investments's PRVA Position: Q3 2025 in Review

Versor Investments sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 36,585 shares — an estimated $841K sold.

Versor Investments first reported a position in PRVA in Q2 2022 and held it in 5 quarters. The position peaked at $841K in Q2 2025. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Versor Investments reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 36,585 Privia Health shares in Q3 2025, an estimated $841K.
  • Versor Investments first reported a position in Privia Health in Q2 2022 and held it in 5 quarters.
  • Versor Investments's Privia Health position peaked at $841K in Q2 2025.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.